To measure the impact of a surgeon's volume on their patient's rate of reoperation after Mid-Urethral Sling (MUS) surgery. MATERIALS AND METHODS: This is a retrospective cohort study evaluating all surgeons performing synthetic mesh MUS for stress urinary incontinence (SUI) at a multi-centered managed care organization of 5 million patients from 2005 to 2016. Physicians' CPT and ICD-9/10 codes were used to identify the procedures and reoperations performed. The system-wide medical record was queried for demographic and perioperative data. The primary outcome was the overall reoperation rate after MUS. Secondary outcomes were the specific reoperation rates for surgical failure and complications. Concentration curves were used to identify the impact of a surgeon's surgical volume on their rate of reoperation. Demographics, characteristics, and reoperation of patients operated by high and lower volume surgeons were compared using chi-square for categorical variables and Wilcoxon rank sum for continuous variables. Poisson regression models with a robust error variance were used to calculate the unadjusted and the adjusted risk ratios of reoperation using age, BMI, marital status, race, parity, vaginal estrogen use, smoking, diabetes, and menopausal status as covariates. RESULTS: Four hundred twenty-three surgeons performed 13,495 MUS over the study period and patients had a mean of 4.4 years of follow up. High volume surgeons (>40 MUS/year, 95th percentile) performed 45% of MUS in this cohort and had overall lower rate of reoperation (3.37% vs. 4.24%, p<0.01) compared to lower volume surgeons. High volume surgeons had a lower rate of reoperation for surgical failure (2.58% vs. 3.64%, p<0.01), with a lower rate of repeat MUS (1.46% vs. 2.56%, p<0.01) and laparoscopic retropubic urethropexy (0.05% vs. 0.30%, p<0.01); however bulking injection for surgical failure was more common (0.92% vs. 0.80%, p¼0.02). Rates of reoperation for complications were similar between the two groups (0.99% vs. 0.96%, p¼0.08). For patient's requiring a reoperation secondary to complication, rates of reoperation for mesh exposure (0.15% vs. 0.27%, p¼0.13), hemorrhage/bleeding (0.08% vs. 0.04%, p¼0.18), pain (0.08% vs. 0.11%, p¼0.94), and infection (0.02% vs. 0.05%, p¼0.37) did not differ between high and lower volume surgeons. Patients who had surgery by a high volume surgeon had a slight increase in reoperation for urinary retention (0.81% vs. 0.67%, p¼0.02). The risk ratio for reoperation comparing high and lower volume surgeons was 0.79 (p¼0.01) in the unadjusted and 0.81 (p¼0.03) in the adjusted model. CONCLUSION: While reoperation rates were low for both high and lower volume surgeons, high volume surgeons have lower overall rates of reoperation after MUS. This effect is seen most dramatically in reoperation for surgical failure, where patients who do not have surgery with a high volume surgeon are over 40% more likely to have post-operative SUI that required reoperation.
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DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:
Alexander Berger: Nothing to disclose; Jasmine Tan OBJECTIVES: We aimed to determine if an adjuvant posterior repair (PR) at transvaginal apical suspension is associated with improved surgical success.
MATERIALS AND METHODS:
This secondary analysis of a multicenter randomized trial compared 24-month outcomes in 190 participants who had a posterior repair (PR group) and 184 who did not (NoPR) at the time of sacrospinous ligament fixation (SSLF) or uterosacral ligament suspension (USLS). Concomitant PR was performed at surgeon's discretion. Primary outcome of "surgical success" was defined as no prolapse beyond the hymen, C -2/3 x TVL, no bothersome vaginal bulge, and no retreatment at 24 months. These individual components were secondary outcomes. Propensity score (PS) methods were employed to build models that balanced PR and NoPR groups for ethnographic factors and preoperative POPQ values. Adjusted ORs were calculated to predict surgical success based on the performance of a PR. Groups were also compared with unadjusted Chi Square analyses. An unadjusted probability curve was created for surgical success as predicted by preoperative GH. RESULTS: There were no group differences in surgical success using PS methods (66.7% PR vs 62.0% no PR, aOR 1.07 (0.56, 2.07), p: 0.83) or unadjusted test (66.2% PR vs. 61.7% NoPR, p: 0.47 ). Individual outcome measures also did not differ (Table) . There was high variation in performance of PR by surgeon [IQR 15%-79%]. The PR group was more likely to have greater values of Ap, Bp, GH, and TVL. The unadjusted probability of overall success at 24 months regardless of PR, decreased with increasing GH such that a GH of 4.5 cm was associated with 65.8% success (95% CI: 60.1%, 71.1%) (Figure) . CONCLUSION: Concomitant PR at SSLS or USLS does not improve surgical success after adjusting for baseline covariates using propensity scores. Posterior repair does not compensate for the pathophysiology leading to levator plate attenuation and enlarged preoperative GH which remains prognostic of prolapse recurrence. 
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